Viveon Health Acquisition Corp.
VHAQ · AMEX
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.68 | -0.04 | 0.02 | -0.29 |
| FCF Yield | -0.00% | -0.21% | -0.49% | -0.64% |
| EV / EBITDA | -115.31 | 24.15 | -65.50 | 124.98 |
| Quality | ||||
| ROIC | -3.46% | 1.61% | -1.89% | -1.27% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.66 | -0.09 | 0.19 | -1.24 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 99.94% | 40.10% | 22.73% | -36.14% |
| Safety | ||||
| Net Debt / EBITDA | -7.45 | 0.73 | -0.56 | -1.50 |
| Interest Coverage | 0.00 | 0.11 | -1.27 | -2.46 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -4.14 | -2.94 |
| Cash Conversion Cycle | 0.00 | -206.40 | -114.52 | -115.22 |